Literature DB >> 2807674

Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.

Y Okuno1, T Nakao, N Ishida, T Konno, H Mizutani, Y Fukuyama, T Sato, S Isomura, S Ueda, I Kitamura.   

Abstract

The Japanese Committee for the National Registry of Subacute Sclerosing Panencephalitis (SSPE) confirmed that 215 cases of SSPE occurred in the 20 years from 1966 to 1985, as discovered in the 10-year surveillance from April 1976 through March 1986. The annual incidence in recent years has been between 10 and 23 cases. Among cases with a certain history of measles illness or measles vaccination, 184 (90.2%) had a history of measles illness without receiving measles vaccine. There were 11 probable measles vaccine-associated cases (5.4%), three (1.5%) being vaccinated with a combined use of killed and live vaccine and eight (3.9%) with further attenuated live vaccine. There were nine cases (4.4%) without a history of either measles illness or measles vaccination. Intervals between measles illness and the onset of SSPE varied from 1 to 16 years (mean, 7.0 years). The periods following measles vaccination with further attenuated live vaccine were 2 to 11 years (mean, 4.6 years). Annual incidence rates of SSPE per million cases of measles ranged between 6.1 and 40.9 (mean, 16.1) in the 10 measles epidemic years 1968-1977, and those following vaccination with further attenuated live vaccine were zero in most years and at the highest 3.08 (mean, 0.9) per million doses of distributed vaccine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807674     DOI: 10.1093/ije/18.3.684

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  6 in total

1.  Subacute sclerosing panencephalitis : diagnosis and drug treatment options.

Authors:  B Anlar
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

2.  Serodiagnosis of subacute sclerosing panencephalitis by enzyme linked immunosorbent assay.

Authors:  V Lakshmi; Y Malathy; R R Rao
Journal:  Indian J Pediatr       Date:  1993 Jan-Feb       Impact factor: 1.967

Review 3.  Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus.

Authors:  Renata da Fontoura Budaszewski; Veronika von Messling
Journal:  Viruses       Date:  2016-10-11       Impact factor: 5.048

4.  Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference.

Authors:  Momoko Otaki; Kiyonao Sada; Hiroyasu Kadoya; Motoko Nagano-Fujii; Hak Hotta
Journal:  Antiviral Res       Date:  2006-02-13       Impact factor: 5.970

5.  The average cost of measles cases and adverse events following vaccination in industrialised countries.

Authors:  Hélène Carabin; W John Edmunds; Ulla Kou; Susan van den Hof; Van Hung Nguyen
Journal:  BMC Public Health       Date:  2002-09-19       Impact factor: 3.295

Review 6.  Subacute sclerosing panencephalitis in pregnancy.

Authors:  Michael H Chiu; Bonnie Meatherall; Ana Nikolic; Kristine Cannon; Kevin Fonseca; Jeffrey T Joseph; Judy MacDonald; Kanti Pabbaraju; Raymond Tellier; Sallene Wong; Marcus W Koch
Journal:  Lancet Infect Dis       Date:  2016-01-20       Impact factor: 25.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.